Menu
Currency
GWAS Study

Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.

Kottyan LC, Maddox A, Braxton JR et al.

29904099 PubMed ID
GWAS Study Type
4944 Participants
36 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KL
Kottyan LC
MA
Maddox A
BJ
Braxton JR
SE
Stucke EM
MV
Mukkada V
PP
Putnam PE
AJ
Abonia JP
CM
Chehade M
WR
Wood RA
PR
Pesek RD
VB
Vickery BP
FG
Furuta GT
DP
Dawson P
SH
Sampson HA
ML
Martin LJ
KJ
Kelly JA
KR
Kimberly RP
SK
Sivils K
GP
Gaffney PM
KK
Kaufman K
HJ
Harley JB
RM
Rothenberg ME
Chapter II

Abstract

Summary of the research findings

Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus triggered by immune hypersensitivity to food. Herein, we tested whether genetic risk factors for known, non-allergic, immune-mediated diseases, particularly those involving autoimmunity, were associated with EoE risk. We used the high-density Immunochip platform, encoding 200,000 genetic variants for major auto-immune disease. Accordingly, 1214 subjects with EoE of European ancestry and 3734 population controls were genotyped and assessed using data directly generated or imputed from the previously published GWAS. We found lack of association of EoE with the genetic variants in the major histocompatibility complex (MHC) class I, II, and III genes and nearly all other loci using a highly powered study design with dense genotyping throughout the locus. Importantly, we identified an EoE risk locus at 16p13 with genome-wide significance (Pcombined=2.05 × 10-9, odds ratio = 0.76-0.81). This region is known to encode for the genes CLEC16A, DEXI, and CIITI, which are expressed in immune cells and esophageal epithelial cells. Suggestive EoE risk were also seen 5q23 (intergenic) and 7p15 (JAZF1). Overall, we have identified an additional EoE risk locus at 16p13 and highlight a shared and unique genetic etiology of EoE with a spectrum of immune-associated diseases.

1,210 European ancestry cases, 3,734 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

4944
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.